128 related articles for article (PubMed ID: 35850212)
1. The potent α
Frau R; Devoto P; Aroni S; Saba P; Sagheddu C; Siddi C; Santoni M; Carli M; Gessa GL
Neuropharmacology; 2022 Oct; 217():109192. PubMed ID: 35850212
[TBL] [Abstract][Full Text] [Related]
2. Noradrenergic terminals are the primary source of α
Devoto P; Flore G; Saba P; Scheggi S; Mulas G; Gambarana C; Spiga S; Gessa GL
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():97-103. PubMed ID: 30472147
[TBL] [Abstract][Full Text] [Related]
3. Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex.
Devoto P; Sagheddu C; Santoni M; Flore G; Saba P; Pistis M; Gessa GL
Front Pharmacol; 2020; 11():588160. PubMed ID: 33071798
[TBL] [Abstract][Full Text] [Related]
4. Combined α
Sagheddu C; Devoto P; Aroni S; Saba P; Pistis M; Gessa GL
Front Pharmacol; 2023; 14():1238115. PubMed ID: 37680715
[TBL] [Abstract][Full Text] [Related]
5. Alpha2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex.
Devoto P; Flore G; Pira L; Longu G; Gessa GL
J Neurochem; 2004 Feb; 88(4):1003-9. PubMed ID: 14756822
[TBL] [Abstract][Full Text] [Related]
6. Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex.
Pan WH; Yang SY; Lin SK
Synapse; 2004 Jul; 53(1):44-52. PubMed ID: 15150740
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of dopamine-beta-hydroxylase enhances dopamine release from noradrenergic terminals in the medial prefrontal cortex.
Devoto P; Flore G; Saba P; Frau R; Gessa GL
Brain Behav; 2015 Oct; 5(10):e00393. PubMed ID: 26516613
[TBL] [Abstract][Full Text] [Related]
8. Basolateral amygdala modulation of the nucleus accumbens dopamine response to stress: role of the medial prefrontal cortex.
Stevenson CW; Gratton A
Eur J Neurosci; 2003 Mar; 17(6):1287-95. PubMed ID: 12670317
[TBL] [Abstract][Full Text] [Related]
9. Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by alpha2-autoreceptors.
Gobert A; Billiras R; Cistarelli L; Millan MJ
J Neurosci Methods; 2004 Dec; 140(1-2):141-52. PubMed ID: 15589344
[TBL] [Abstract][Full Text] [Related]
10. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
11. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
Hu XT; White FJ
Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
[TBL] [Abstract][Full Text] [Related]
12. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.
Andersson JL; Nomikos GG; Marcus M; Hertel P; Mathé JM; Svensson TH
Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):374-85. PubMed ID: 8532065
[TBL] [Abstract][Full Text] [Related]
13. Disulfiram stimulates dopamine release from noradrenergic terminals and potentiates cocaine-induced dopamine release in the prefrontal cortex.
Devoto P; Flore G; Saba P; Cadeddu R; Gessa GL
Psychopharmacology (Berl); 2012 Feb; 219(4):1153-64. PubMed ID: 21863234
[TBL] [Abstract][Full Text] [Related]
14. Alpha 1 (but not alpha 2)-adrenoceptor agonists in combination with the dopamine D2 agonist quinpirole produce locomotor stimulation in dopamine-depleted mice.
Eshel G; Ross SB; Kelder D; Edis LE; Jackson DM
Pharmacol Toxicol; 1990 Aug; 67(2):123-31. PubMed ID: 1979437
[TBL] [Abstract][Full Text] [Related]
15. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.
Hu XT; Wachtel SR; Galloway MP; White FJ
J Neurosci; 1990 Jul; 10(7):2318-29. PubMed ID: 1973947
[TBL] [Abstract][Full Text] [Related]
16. Alpha-2A but not 2B/C noradrenergic receptors in ventral tegmental area regulate phasic dopamine release in nucleus accumbens core.
Joanna B; Michal K; Agnieszka WB; Katarzyna Z; Marzena M; Ryszard P; Wojciech S
Neuropharmacology; 2022 Dec; 220():109258. PubMed ID: 36116534
[TBL] [Abstract][Full Text] [Related]
17. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists.
See RE; Sorg BA; Chapman MA; Kalivas PW
Neuropharmacology; 1991 Dec; 30(12A):1269-74. PubMed ID: 1686300
[TBL] [Abstract][Full Text] [Related]
18. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex.
Devoto P; Flore G; Pani L; Gessa GL
Mol Psychiatry; 2001 Nov; 6(6):657-64. PubMed ID: 11673793
[TBL] [Abstract][Full Text] [Related]
19. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
20. Dual effects of D-amphetamine on dopamine neurons mediated by dopamine and nondopamine receptors.
Shi WX; Pun CL; Zhang XX; Jones MD; Bunney BS
J Neurosci; 2000 May; 20(9):3504-11. PubMed ID: 10777813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
